在晚期霍奇金淋巴瘤的治疗策略
Eldad J Dann1,2,3, René-Olivier Casasnovas4,5
1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa 3109601, Israel.
Cancers
|June 19, 2024
概括
晚期霍奇金淋巴瘤的治疗已经显著发展,包括预后得分,临时PET/CT扫描和新型化疗方案. 最近的进展包括检查点抑制剂,有望改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 在过去的三十年中,在治疗晚期霍奇金淋巴瘤 (HL) 方面取得了重大进展.
- 关键的发展包括国际预后评分 (IPS) 系统和使用临时PET/CT扫描作为治疗指导.
- 已经引入了不断变化的化疗方案,如升级的BEACOPP及其修改.
研究的目的:
- 审查最近的研究,这些研究可能会改变目前的高级HL治疗实践.
- 分析新治疗策略对霍奇金淋巴瘤管理的影响.
主要方法:
- 对最近发表的关于晚期霍奇金淋巴瘤治疗研究的综述.
- 分析包括化疗,抗体结合物和检查点抑制剂在内的治疗进展.
主要成果:
- 治疗决策现在整合IPS和临时PET/CT结果,使得负面扫描的安全降级.
- 已经开发出了像布伦图西马布维多丁 (BV) -AVD和BrECADD这样的新方案.
- 在初步结果中,检查点抑制剂,特别是与化疗 (nivolumab-AVD) 结合的抗PD1抑制剂,在BV-AVD上表现出优势.
结论:
- 晚期HL的治疗策略正在不断发展,有效性和安全性得到改善.
- 检查点抑制剂的整合代表了第一线治疗的重大进步.
- 目前正在进行的研究旨在进一步完善治疗方案,以获得更好的患者结果.
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


